Yamaguchi A, Tsukioka Y, Kurosaka Y, Nishimura G, Kanno M, Yonemura Y, Miyazaki I
Department of Surgery II, School of Medicine, Kanazawa University, Japan.
Oncology. 1993 Mar-Apr;50(2):121-6. doi: 10.1159/000227162.
We studied the proliferative activity in endoscopically biopsied tumors by means of argyrophil-protein nucleolar organizer region (AgNOR) scores. AgNOR scores of 109 colorectal cancers ranged from 2.48 to 6.72 (mean: 3.27 +/- 0.52). The 109 tumors were divided into two groups by the median value of AgNOR counts. There was no significant correlation between the AgNOR scores and the histologic type, invasion of bowel wall, lymph node metastases or peritoneal metastases. There was a significant association between the AgNOR scores and lymphatic invasion or liver metastases. Patients with higher AgNOR score tumors had significantly poorer prognoses than those with lower AgNOR score tumors. In Dukes' stage C, especially, the survival rate for patients with higher AgNOR score tumors was significantly lower than for those with lower AgNOR score tumors. Recurrence was found in 8.7% of the tumors with lower AgNOR scores and 19.4% of the tumors with higher scores. Aneuploid tumors had higher AgNOR scores than tumors with the diploid pattern. The results suggest that the AgNOR scores may possibly be a useful prognostic marker of colorectal cancer.
我们通过嗜银蛋白核仁组织区(AgNOR)评分研究了经内镜活检肿瘤的增殖活性。109例结直肠癌的AgNOR评分范围为2.48至6.72(平均值:3.27±0.52)。根据AgNOR计数的中位数将这109例肿瘤分为两组。AgNOR评分与组织学类型、肠壁侵犯、淋巴结转移或腹膜转移之间无显著相关性。AgNOR评分与淋巴管侵犯或肝转移之间存在显著关联。AgNOR评分较高的肿瘤患者的预后明显比AgNOR评分较低的肿瘤患者差。尤其是在Dukes C期,AgNOR评分较高的肿瘤患者的生存率明显低于AgNOR评分较低的肿瘤患者。AgNOR评分较低的肿瘤复发率为8.7%,评分较高的肿瘤复发率为19.4%。非整倍体肿瘤的AgNOR评分高于二倍体模式的肿瘤。结果表明,AgNOR评分可能是结直肠癌有用的预后标志物。